These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1399 related items for PubMed ID: 33231312

  • 1. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay.
    Kang K, Huang L, Ouyang C, Du J, Yang B, Chi Y, He S, Ying L, Chen G, Wang J.
    J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
    Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y, Wang J, Huang B, Lin Y, Yang J, Cai W, Wang X, Cheng J, Chen Z, Sun K, Pan W, Zhan Z, Chen L, Ye F.
    J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
    [Abstract] [Full Text] [Related]

  • 4. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    Pieri M, Nuccetelli M, Nicolai E, Sarubbi S, Grelli S, Bernardini S.
    J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T, Colin M, Giachè S, Gubavu C, Seve A, Rzepecki V, Chevereau-Choquet M, Kiani C, Rodot V, Lionnet E, Courtellemont L, Guinard J, Pialoux G, Hocqueloux L.
    PLoS One; 2020 Apr; 15(9):e0237694. PubMed ID: 32941461
    [Abstract] [Full Text] [Related]

  • 6. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C, Ichou H, Damond F, Bouvet E, Chaix ML, Ferré V, Delaugerre C, Mahjoub N, Larrouy L, Le Hingrat Q, Visseaux B, Mackiewicz V, Descamps D, Fidouh-Houhou N.
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C, Bu G, Sun Y, Ren C, Qu M, Gao Y, Zhu Y, Wang L, Sun L, Liu Y.
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.
    Qian C, Zhou M, Cheng F, Lin X, Gong Y, Xie X, Li P, Li Z, Zhang P, Liu Z, Hu F, Wang Y, Li Q, Zhu Y, Duan G, Xing Y, Song H, Xu W, Liu BF, Xia F.
    Clin Chem Lab Med; 2020 Aug 27; 58(9):1601-1607. PubMed ID: 32609640
    [Abstract] [Full Text] [Related]

  • 10. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R, Kurano M, Morita Y, Shimura T, Nakano Y, Qian C, Xia F, He F, Kishi Y, Okada J, Yoshikawa N, Nagura Y, Okazaki H, Moriya K, Seto Y, Kodama T, Yatomi Y.
    PLoS One; 2021 Aug 27; 16(3):e0247711. PubMed ID: 33661990
    [Abstract] [Full Text] [Related]

  • 11. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS, Péré H, Tonen-Wolyec S, Longo JD, Moussa S, Mbopi-Keou FX, Mossoro-Kpinde CD, Grésenguet G, Veyer D, Bélec L.
    J Med Virol; 2021 Apr 27; 93(4):2196-2203. PubMed ID: 33107601
    [Abstract] [Full Text] [Related]

  • 12. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
    Péré H, Mboumba Bouassa RS, Tonen-Wolyec S, Podglajen I, Veyer D, Bélec L.
    J Virol Methods; 2021 Apr 27; 290():114067. PubMed ID: 33476707
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y, Imai K, Matsuoka M, Fukada A, Kubota K, Sato M, Takada T, Noguchi S, Tarumoto N, Maesaki S, Takeuchi S, Maeda T.
    J Med Virol; 2022 Jan 27; 94(1):335-341. PubMed ID: 34524695
    [Abstract] [Full Text] [Related]

  • 14. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response.
    David A, Scott L, Jugwanth S, Gededzha M, Kahamba T, Zwane N, Mampeule N, Sanne I, Stevens W, Mayne ES.
    J Immunol Methods; 2021 Sep 27; 496():113096. PubMed ID: 34242653
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
    Wu LX, Wang H, Gou D, Fu G, Wang J, Guo BQ.
    J Clin Lab Anal; 2021 Jan 27; 35(1):e23649. PubMed ID: 33184940
    [Abstract] [Full Text] [Related]

  • 19. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J, Yorsaeng R, Posuwan N, Puenpa J, Sudhinaraset N, Chirathaworn C, Poovorawan Y.
    Virol J; 2021 Mar 09; 18(1):52. PubMed ID: 33750394
    [Abstract] [Full Text] [Related]

  • 20. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies.
    Solastie A, Virta C, Haveri A, Ekström N, Kantele A, Miettinen S, Lempainen J, Jalkanen P, Kakkola L, Dub T, Julkunen I, Melin M.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0113121. PubMed ID: 34787485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.